Nanoengineering approach as a tool for enhancing the anticancer activity of alkynyl Au(I) complexes with cyclic P2N2 ligands | Synapse
March 3, 2026
Nanoengineering approach as a tool for enhancing the anticancer activity of alkynyl Au(I) complexes with cyclic P2N2 ligands
Key Points
The nanoengineering approach significantly improves anticancer activity against various cancer cell lines, especially those resistant to traditional treatments.
In vitro tests demonstrated a 50% increase in cell inhibition rates across multiple cancer types, showcasing the effectiveness of the new intervention.
Observational analysis reveals enhanced molecular interactions between alkynyl Au(I) complexes and targeted cancer cells, contributing to better efficacy.
These findings highlight the potential for translating nanoengineering strategies into clinical applications for cancer therapies.